Fujifilm Biotechnologies recently announced it opened a $3.2 billion commercial-scale cell culture manufacturing site in Holly Springs, N.C., with eight 20,000-liter bioreactors and plans to double capacity. The facility is one of the largest commercial cell culture sites in North America, the company said. Phase one spans drug substance and drug product manufacturing, with finished… The post Fujifilm Biotechnologies opens $3.2B manufacturing site in North Carolina appeared first on Pharmac...
